Shachar Peles

Internal Medicine

202 S Park St
Madison, WI 53715

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.

Impact of a Best Practices Program in Patients with Relapsed/Refractory Multiple Myeloma Receiving Selinexor.

Journal: Current oncology (Toronto, Ont.)

Published: November 22, 2023

A Fresh Breath of Oxygen: Red Blood Cell Exchange Transfusion in Sickle Cell and COVID-19.

A Fresh Breath of Oxygen: Red Blood Cell Exchange Transfusion in Sickle Cell and COVID-19.

Journal: Clinical case reports

Published: March 15, 2021

Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.

Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis.

Journal: Blood advances

Published: August 04, 2020

Acute ST-segment Elevation Myocardial Infarction as the First Manifestation of Essential Thrombocytosis.

Acute ST-segment Elevation Myocardial Infarction as the First Manifestation of Essential Thrombocytosis.

Journal: Cureus

Published: April 24, 2019

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma.

Journal: Blood

Published: October 21, 2016

Showing 1-5 of 5

Last Updated: 09/26/2026